---
title: "Atlas Soya Proteins (519067) Financials & Shareholding"
symbol: "519067"
company: "Atlas Soya Proteins Ltd"
canonical: "https://tapetide.com/stocks/519067"
bse_code: "519067"
generated_at: "2026-11-05T01:51:15.041Z"
---

# Atlas Soya Proteins (519067)

Canonical page: https://tapetide.com/stocks/519067

## Company

- **BSE code:** 519067
- **In the F&O segment:** No

## Key Insights

### Strengths

- Company has reduced debt.

### Weaknesses

- Company has low interest coverage ratio.
- Company's cost of borrowing seems high

## Growth Rate

Growth computed from the financial statements below. A window with no rate gives the reason instead of a figure.

Annual windows: The latest annual results are more than two years old, so no annual growth is shown.

Trailing twelve months: No quarterly results are reported.

## Financial Statements

Not shown: Quarterly Results and Cash Flow. Not this company's figures: left behind by an earlier update and not confirmed by the latest one.

### Profit & Loss

Figures in ₹ crore unless the row name gives another unit.

| Item | Mar 2006 | Mar 2007 |
| --- | ---: | ---: |
| Sales | 0 | 0 |
| Expenses | 0.03 | 3.03 |
| Operating Profit | -0.03 | -3.03 |
| Other Income | 0.19 | 3.04 |
| Interest | 0.54 | 0.07 |
| Depreciation | 0 | 0 |
| Profit before tax | -0.38 | -0.06 |
| Tax % | 0% | 0% |
| Net Profit | -0.38 | -0.06 |
| Dividend Payout % | 0% | 0% |

### Balance Sheet

Figures in ₹ crore unless the row name gives another unit.

| Item | Mar 2006 | Mar 2007 |
| --- | ---: | ---: |
| Equity Capital | 1.77 | 1.77 |
| Reserves | -1.51 | -1.57 |
| Borrowings | 0.99 | 0.36 |
| Other Liabilities | 1.77 | 0.05 |
| Total Liabilities | 3.02 | 0.61 |
| Fixed Assets | 0.18 | 0 |
| CWIP | 0 | 0 |
| Investments | 0 | 0 |
| Other Assets | 2.84 | 0.61 |
| Total Assets | 3.02 | 0.61 |

### Ratios

| Item | Mar 2006 | Mar 2007 |
| --- | ---: | ---: |
| ROCE % | — | -165.75% |

## Shareholding Pattern

Not shown: Shareholding Pattern. Not this company's figures: left behind by an earlier update and not confirmed by the latest one.

## Documents

### Exchange filings

| Date | Document |
| --- | --- |
| 14 Feb 2026 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=097707c3-5628-487b-92e8-43fd0791ffe4.pdf) |
| 13 Feb 2026 | [Monthly Report On Special Window For Re-Lodgement Of Transfer Requests Of Physical Shares For The Month Of January, 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d7d6fec-50eb-4eed-92f7-c78830a268c6.pdf) |
| 11 Feb 2026 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6cd0dee5-a1fe-4b94-adda-311369769cfd.pdf) |
| 10 Feb 2026 | [Unaudited Financial Results 3Rd Quarter & Nine Months Ended 31-12-2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8043023a-590e-45d8-af59-a88d8b8a2f2e.pdf) |
| 10 Feb 2026 | [Board Meeting Outcome for Unaudited Financial Results Quarter Ended 31-12-2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fa0696ab-831b-45df-aab0-f2684a1bcbd4.pdf) |

## Frequently Asked Questions about Atlas Soya Proteins

### Where is Atlas Soya Proteins Ltd (519067) listed?

Atlas Soya Proteins Ltd trades under code 519067 on the BSE.

## Company Information

- **Face Value:** ₹10

---

Negative figures use an ASCII hyphen-minus (-) so they parse as numbers. Amounts are in Indian rupees; "Cr" is crore (10 million). Dates are Indian Standard Time.

Financial statements, shareholding and filings are as reported by the company. Price, volume and 52-week levels are market data. Technical indicators are computed by Tapetide from daily prices. The Tapetide Score is Tapetide’s own analysis. Analyst ratings and forecasts are the published estimates of third-party analysts, not company statements. The AI sections are generated text.

For research and information only, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Generated 5 Nov 2026, 07:21 IST.